A case of G1013R FBN1 mutation: A potential genotype-phenotype correlation in severe Marfan syndrome.
Brooke R WillisBrian Hon-Yin ChungKavitha RethanaveluJasmine L F FungRosanna M S WongPeter HuiKit S YeungIvan F M LoBrian Hon-Yin ChungPublished in: American journal of medical genetics. Part A (2020)
Marfan Syndrome (MFS) is an autosomal dominant connective tissue disorder with a wide range of severities. Ninety-five percent of MFS probands have a mutation in the fibrillin-1 gene (FBN1); however, there are a high number of unique mutations complicating attempts at establishing any phenotype-genotype correlations for this disease (Tiecke et al., European Journal of Human Genetics, 2001, 9, 13-21). One of the few extant genotype-phenotype correlations is in exon 24-32 which have been associated with a severe pediatric presentation of neonatal MFS with predominately cardiovascular symptoms. We present a 24-year-old male patient with a heterozygous de novo variant NM_000138.4: c.3037G>A (p.G1013R) located in exon 25 of the FBN1 gene. The patient was found to have dysplastic mitral and tricuspid valves with dilated aortic root at 9 months of age. This is a notable case in that the location of this patient's mutation and his age of symptom onset would indicate a guarded prognosis. Further, this mutation, FBN1 G1013R, has been reported in the literature in four other unrelated patients all of whom presented at a young age with cardiac involvement and all of whom had relative longevity when compared to other patients with mutations in this exon 24-32 hot spot. These findings may represent a more specific genotype-phenotype correlation within this mutational hot spot.
Keyphrases
- case report
- aortic valve
- left ventricular
- early onset
- end stage renal disease
- ejection fraction
- mitral valve
- endothelial cells
- chronic kidney disease
- systematic review
- newly diagnosed
- aortic stenosis
- copy number
- heart failure
- risk assessment
- gene expression
- aortic dissection
- photodynamic therapy
- aortic valve replacement
- climate change
- transcription factor
- drug induced
- young adults
- aortic aneurysm